In the athletic world, the World Anti-Doping Agency (WADA) added BPC-157 to its Prohibited List in 2022 under the S0 category of Non-Approved Substances. This means its use is banned at all times for athletes competing under WADA-affiliated organizations
The dual action is thought to offer a more balanced metabolic effect than targeting GLP-1 alone, though individual responses can vary
Current frequently used GLP-1-based medications include: Ozempic (semaglutide) : A GLP-1 receptor agonist approved for type 2 diabetes management
By comparison, the injectable version of Wegovy can cost more than $1,300 for a 28-day supply without savings programs or insurance
Front Neuroendocrinol (2016) 42:7692
It helps regulate metabolism, supports protein synthesis (which is how you build muscle), encourages the breakdown of fat for energy, supports bone growth and density, and helps maintain healthy organ function